scientifyRESEARCH
research funding database

RESEARCH FUNDING

Drug Development RFP (Alzheimer’s Disease worldwide)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Drug Development RFP from the Alzheimer’s Drug Discovery Foundation provides funding for investigational new drug (IND)-enabling studies (or the international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias. The grant is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 5 million USD (direct costs only). There are three assessment rounds per year.

The next letter of intent is due May 13, 2024, and the full application is due on July 22, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

We value your opinion

Complete our 1-min user survey and receive complimentary full access to our premium research funding database.

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time